GLP-1/GIP/glucagon triple agonist

Retatrutide — Research Reference Guide

Retatrutide is a triple agonist research compound acting on GLP-1, GIP and glucagon receptors. This guide summarises the handling and batch-verification points laboratories typically review.

Triple receptor profile

Retatrutide is studied for its combined GLP-1, GIP and glucagon receptor engagement — a profile distinct from earlier dual or mono-agonist peptides.

Lab handling

Lyophilised storage at 2–8°C, reconstitution with bacteriostatic water and refrigerated in-use stability are standard. Always defer to your internal SOPs and the printed COA.

Why batch transparency matters

Triple agonists are sequence-sensitive — small impurities can shift assay readouts. Regena publishes HPLC purity for every batch on the lab reports page.

Frequently asked questions

Why are there so many strengths?+

Different research protocols need different total mg per kit. Right-sizing avoids waste and limits exposure to reconstituted material past its stability window.

Is retatrutide in stock?+

Stock rotates by batch — check the Peptide Library page for live availability.

Continue your research

Trusted reference supplier · Verified across review platforms